Abstract:Objectives Fungal infective endocarditis is a rare and poorly understood complication of fungemia. Given the rarity of this infection, few studies are available on Fungal IE. Most epidemiologic data are derived from case reports. This study was conducted to explore the clinical characteristics, treatment patterns, and outcomes of patients with Fungal IE. Methods We conducted a prospective, observational study in the Fuwai Hospital, National Center for Cardiovascular disease, including all consecutive patients with a definite diagnosis of IE admitted from January 2006 through December 2011. The overall characteristics and risk factors for death from FE were analysed. Results Between January 2006 and December 2011, a total of 22 patients with fungal infective endocarditis were identified. The mean age at presentation was 32±6 years, with a slight male preponderance. There were 16 (78%) patients with involvement of a mechanical prosthesis; the majority (64%) had early prosthetic valve endocarditis (PVE), five cases (23%) of native valve endocarditis (NVE), one case of pacemaker endocarditis. None of them were intravenous drug users. Most patients (82%) had healthcare-associated IE. The aortic valve was most commonly affected, and the most common aetiological agent was Candida species, followed by Histoplasma capsulatum, filamentous fungi and pharyngeal aspergillus. The most common symptom at presentation was persistent infection(77%), followed by weight loss, major vessel embolism, and Anaemia. Major complications occurring during the acute infective phase were also recorded, including renal infarction (73%), New York Heart Association class III–IV heart failure (45%), and neurological complication (36%). Initial therapy consisted of a combination of antifungals in 12 of 22 patients (55%). Eight patients (36%) underwent valve replacement. Pathological evaluation of valve material was of high yield, with organisms identified in 87% of cases who underwent valve replacement surgery. Prosthetic valve fungal endocarditis was associated with a high morbidity and mortality, with 77% of patients experiencing complications and 45% of patients dying of infection-related disease. The overall hospital mortality rate was 66.7%. A better outcome was observed in patients treated with a combined medical and surgical therapy. Conclusions Fungal infective endocarditis is an increasingly prevalent and devastating disease in today9s highly advancing medical practice. An aggressive approach should be considered in patients with prosthetic intravascular devices and significant risk factors for nosocomial fungemia. Microorganism should be investigated particularly by molecular methods on surgical specimens

Contemporary In-Hospital and Long-Term Outcomes of Surgical Management for Fungal Endocarditis.

Isolated Pulmonary Valve Endocarditis with Rapid Progression: a Case Report and Literature Review

Mid-term results of surgical treatment for prosthetic valve endocarditis

Surgical treatment for prosthetic valve endocarditis

A PROSPECTIVE SINGLE-CENTRE STUDY OF FUNGAL INFECTIVE ENDOCARDITIS

Clinical Analysis of 6 Cases of Fungal Endocarditis

Clinical Characterization of Pathogens, Risk Factors and Quality of Life in an Observational Study of Native vs. Prosthetic Aortic Valve Endocarditis Surgery

Surgical Interventions for Complex Native Valve Endocarditis

A clinical analysis of 17 cases of prosthetic valve endocarditis

Late-Term Outcomes of Surgical Treatment of Infective Endocarditis

Pulmonary endarterectomy (PEA): the treatment for chronic thromboembolic pulmonary hypertension (CTEPH)

Key Points in the Surgical Treatment of Infective Endocarditis : a Report of 106 Cases

Surgical treatment of valve endocarditis in high-risk patients and predictors of long-term outcomes

Modifiable risk factors of immediate and long-term outcomes in the operable and inoperable with left-sided infective endocarditis

Long-term results of operation for paravalvular abscess

Co-infection with bacterial and fungal endocarditis at scar tissue in an immunocompromised patient

Open-heart surgery to cure cardiac device related endocarditis

Clinical Analysis of 161 Cases of Surgical Treatment of Infective Endocarditis.

Early Diagnosis and Surgical Treatment of Infective Endocarditis

Treatment for Prosthetic Valve Endocarditis after Mitral Valve Replacement Therapy

Surgical Therapy of Infective Prosthesis Endocarditis following TAVI: A Single Center's Experience